Taleb Soraya, Cancello Raffaella, Clément Karine, Lacasa Daniele
Institut National de la Santé et de la Recherche Médicale, Unité 755, Department of Nutrition, Hôtel-Dieu, Place du parvis Notre-Dame, 75004 Paris, France.
Endocrinology. 2006 Oct;147(10):4950-9. doi: 10.1210/en.2006-0386. Epub 2006 Jul 6.
We previously showed that the cysteine protease cathepsin S (CTSS), known to degrade several components of the extracellular matrix (ECM), is produced by human adipose cells and increased in obesity. Because ECM remodeling is a key process associated with adipogenesis, this prompted us to assess the potential role of CTSS to promote preadipocyte differentiation. Kinetic studies in primary human preadipocytes revealed a modest increase in CTSS gene expression and secretion at the end of differentiation. CTSS activity was maximal in preadipocyte culture medium but decreased thereafter, fitting with increased release of the CTSS endogenous inhibitor, cystatin C, during differentiation. Inhibition of CTSS activity by an exogenous-specific inhibitor added along the differentiation, resulted in a 2-fold reduction of lipid content and expression of adipocyte markers in differentiated cells. Conversely, the treatment of preadipocytes with human recombinant CTSS increased adipogenesis. Moreover, CTSS supplementation in preadipocyte media markedly reduced the fibronectin network, a key preadipocyte-ECM component, the decrease of which is required for adipogenesis. Using immunohistochemistry on serial sections of adipose tissue of obese subjects, we showed that adipose cells staining positive for CTSS are mainly located in the vicinity of fibrosis regions containing fibronectin. Herein we propose that CTSS may promote human adipogenesis, at least in part, by degrading fibronectin in the early steps of differentiation. Taken together, these results indicate that CTSS released locally by preadipocytes promotes adipogenesis, suggesting a possible contribution of this protease to fat mass expansion in obesity.
我们之前发现,已知可降解细胞外基质(ECM)多种成分的半胱氨酸蛋白酶组织蛋白酶S(CTSS)由人类脂肪细胞产生,且在肥胖状态下会增加。由于ECM重塑是与脂肪生成相关的关键过程,这促使我们评估CTSS在促进前脂肪细胞分化方面的潜在作用。对原代人类前脂肪细胞的动力学研究显示,在分化末期CTSS基因表达和分泌有适度增加。CTSS活性在前脂肪细胞培养基中最高,但此后降低,这与分化过程中CTSS内源性抑制剂胱抑素C的释放增加相符合。在分化过程中添加外源性特异性抑制剂抑制CTSS活性,导致分化细胞中脂质含量和脂肪细胞标志物表达降低了2倍。相反,用人重组CTSS处理前脂肪细胞可增加脂肪生成。此外,在前脂肪细胞培养基中补充CTSS可显著减少纤连蛋白网络,纤连蛋白是前脂肪细胞-ECM的关键成分,脂肪生成需要其减少。通过对肥胖受试者脂肪组织连续切片进行免疫组织化学分析,我们发现CTSS染色阳性的脂肪细胞主要位于含有纤连蛋白的纤维化区域附近。在此我们提出,CTSS可能至少部分通过在分化早期降解纤连蛋白来促进人类脂肪生成。综上所述,这些结果表明前脂肪细胞局部释放的CTSS可促进脂肪生成,提示这种蛋白酶可能对肥胖状态下脂肪量的增加有一定作用。